BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Dynex Technologies Names Henry O'Connell President


10/19/2005 5:12:57 PM

CHANTILLY, Va., March 8 /PRNewswire/ -- Dynex Technologies, a global supplier of microplate instrumentation and automation products for the biomedical research, drug-discovery, and clinical-diagnostic markets, announced today that Henry O'Connell has been named president, effective immediately.

"Henry brings to Dynex more than 20 years of experience in the analytical instrumentation, clinical diagnostics, and life science industries," said Robert J. Rosenthal, president and chief executive officer of parent company, Magellan Biosciences, Inc. "A dynamic leader, Henry has the right combination of skills, experience, and know-how to leverage Dynex's strong technology base to serve life-science customers better. He has an excellent track record of delivering continuous quality and operational improvements, and meeting customer needs."

O'Connell comes to Dynex from IDEX Corporation, where he was president/group executive of the Precision Flow Products Group. Prior experience included senior management positions at Promega, Inc., Gilson Inc., Groton Technologies, Upchurch Scientific, and SpectraTech Applied Systems. He started his career in the life-science industry as a research fellow focusing on genetic disease therapeutics at the National Institutes of Health (NIH).

"Dynex has excellent products, a world-class staff, and tremendous opportunities for growth," said O'Connell. "I am very excited to join the company, and over the course of the next few months, will be calling on customers to learn how we can best meet their products and services needs."

O'Connell holds a BS in biology from Wabash College, Crawfordsville, Indiana, an MS in life sciences from the University of Connecticut, and completed coursework in a PhD program in biochemistry at the University of Maryland, leaving to pursue his role at the NIH. In addition to his academic training he has completed six sigma greenbelt training.

About Dynex Technologies, Inc.

Founded in 1952, and headquartered in Chantilly, Virginia, Dynex is a leading manufacturer of products incorporating advance detection and fully automated sample handling used in clinical diagnostics, drug discovery, and biomedical research. Dynex employs approximately 50 people at its facility in Chantilly, and at European subsidiaries, Dynex Technologies Ltd and Dynex Technologies GmbH. Dynex is a wholly owned subsidiary of Magellan Biosciences For more information, visit http://www.dynextechnologies.com/.

Company Contact Media Contact Henry O'Connell Caroline A. Grossman 701.803.1205 781.771.5579

Dynex Technologies

CONTACT: Media Contact: Henry O'Connell of Dynex Technologies, Inc.,+1-701-803-1205; or Media Contact: Caroline A. Grossman for DynexTechnologies, Inc., +1-781-771-5579



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES